tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TGTX Stock Latest News

TG Therapeutics Earnings Call: Strong Growth and Positive Outlook
Company AnnouncementsTG Therapeutics Earnings Call: Strong Growth and Positive Outlook
3d ago
TGTX
TG Therapeutics Reports Strong Q3 2025 Results
PremiumCompany Announcements
TG Therapeutics Reports Strong Q3 2025 Results
4d ago
TGTX
Positive Outlook for TG Therapeutics Driven by Strong Financial Performance and Strategic Initiatives
PremiumRatings
Positive Outlook for TG Therapeutics Driven by Strong Financial Performance and Strategic Initiatives
4d ago
TGTX
Positive Outlook on TG Therapeutics: Strong Revenue Growth and International Expansion Drive Buy Rating
PremiumRatings
Positive Outlook on TG Therapeutics: Strong Revenue Growth and International Expansion Drive Buy Rating
4d ago
TGTX
TG Therapeutics price target raised to $49 from $46 at JPMorgan
PremiumThe Fly
TG Therapeutics price target raised to $49 from $46 at JPMorgan
4d ago
TGTX
Morning Movers: Kenvue surges, Kimberly-Clark sinks after tie up
PremiumThe FlyMorning Movers: Kenvue surges, Kimberly-Clark sinks after tie up
4d ago
SM
CDE
TG Therapeutics reports Q3 EPS $2.43, consensus 22c
Premium
The Fly
TG Therapeutics reports Q3 EPS $2.43, consensus 22c
5d ago
TGTX
TG Therapeutics raises FY25 revenue view $600M from $585M, consensus $588.12M
Premium
The Fly
TG Therapeutics raises FY25 revenue view $600M from $585M, consensus $588.12M
5d ago
TGTX
TG Therapeutics completes enrollment in Phase 3 ENHANCE trial
PremiumThe Fly
TG Therapeutics completes enrollment in Phase 3 ENHANCE trial
11d ago
TGTX
TGTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
TGTX Earnings this Week: How Will it Perform?
11d ago
TGTX
TG Therapeutics’ New Study on Ublituximab: A Potential Game-Changer for Pediatric MS Treatment
PremiumCompany Announcements
TG Therapeutics’ New Study on Ublituximab: A Potential Game-Changer for Pediatric MS Treatment
11d ago
TGTX
TG Therapeutics’ Phase 3 Study: A New Approach to Multiple Sclerosis Treatment
PremiumCompany Announcements
TG Therapeutics’ Phase 3 Study: A New Approach to Multiple Sclerosis Treatment
11d ago
TGTX
TG Therapeutics’ Ublituximab Study: A Potential Game-Changer for RMS Treatment?
PremiumCompany AnnouncementsTG Therapeutics’ Ublituximab Study: A Potential Game-Changer for RMS Treatment?
11d ago
TGTX
TG Therapeutics’ BRIUMVI® Study: Evaluating Safety in Pregnancy
Premium
Company Announcements
TG Therapeutics’ BRIUMVI® Study: Evaluating Safety in Pregnancy
11d ago
TGTX
TG Therapeutics’ BRIUMVI® Study: Real-World Insights for RMS Treatment
Premium
Company Announcements
TG Therapeutics’ BRIUMVI® Study: Real-World Insights for RMS Treatment
11d ago
TGTX
TG Therapeutics’ BRIUMVI™ Breast Milk Study: Key Insights for Investors
PremiumCompany Announcements
TG Therapeutics’ BRIUMVI™ Breast Milk Study: Key Insights for Investors
11d ago
TGTX
TG Therapeutics’ Promising Phase 1 Study on Azer-cel for Autoimmune Disorders
PremiumCompany Announcements
TG Therapeutics’ Promising Phase 1 Study on Azer-cel for Autoimmune Disorders
11d ago
TGTX
TG Therapeutics assumed with a Buy at H.C. Wainwright
PremiumThe Fly
TG Therapeutics assumed with a Buy at H.C. Wainwright
1M ago
TGTX
TG announces updated data presentations from ULTIMATE I, II Phase 3 trials
PremiumThe Fly
TG announces updated data presentations from ULTIMATE I, II Phase 3 trials
1M ago
TGTX
TG Therapeutics price target raised to $55 from $53 at B. Riley
PremiumThe FlyTG Therapeutics price target raised to $55 from $53 at B. Riley
2M ago
TGTX
TG Therapeutics says enrollment commenced for Phase 3 trial of BRIUMVI
Premium
The Fly
TG Therapeutics says enrollment commenced for Phase 3 trial of BRIUMVI
2M ago
TGTX
Alphabet jumps after avoiding worst case in antitrust ruling: Morning Buzz
Premium
The Fly
Alphabet jumps after avoiding worst case in antitrust ruling: Morning Buzz
2M ago
F
M

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >